Oruka Therapeutics (ORKA) Change in Accured Expenses (2010 - 2026)
Oruka Therapeutics' quarterly Change in Accured Expenses came in at -$1.3 million in Q1 2026, down 156.28% year-on-year from $2.3 million in Q1 2025, and down 159.08% quarter-over-quarter from $2.2 million in Q4 2025.
Oruka Therapeutics has reported Change in Accured Expenses for 17 years, with the latest figure at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 156.28% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 25.06% YoY), and the FY2025 full-year result was $7.2 million, up 120.08% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$1.3 million, down from $2.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $4.8 million in Q3 2025, with the low at -$2.1 million in Q2 2025.
- Average Change in Accured Expenses over 5 years is $483882.4, with a median of $62000.0 recorded in 2023.
- Year-over-year, Change in Accured Expenses plunged 1340.98% in 2022 and soared 6215.38% in 2024.
- Tracing ORKA's Change in Accured Expenses over 5 years: stood at -$342000.0 in 2022, then jumped by 107.6% to $26000.0 in 2023, then soared by 6215.38% to $1.6 million in 2024, then soared by 34.41% to $2.2 million in 2025, then slumped by 159.08% to -$1.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), $2.2 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.30 Mn |
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 689,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | -116,000.00 |
| Sep 30, 2023 | -116,000.00 |
| Jun 30, 2023 | -45,000.00 |
| Jun 30, 2023 | -45,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | -342,000.00 |
| Dec 31, 2022 | -342,000.00 |
| Sep 30, 2022 | -457,000.00 |
| Sep 30, 2022 | -457,000.00 |
| Jun 30, 2022 | 622,000.00 |
| Jun 30, 2022 | 622,000.00 |
| Mar 31, 2022 | -757,000.00 |
| Mar 31, 2022 | -757,000.00 |
| Dec 31, 2021 | -800,000.00 |
| Dec 31, 2021 | -800,000.00 |
| Sep 30, 2021 | 580,000.00 |
| Sep 30, 2021 | 580,000.00 |
| Jun 30, 2021 | 269,000.00 |
| Jun 30, 2021 | 269,000.00 |
| Mar 31, 2021 | 61,000.00 |
| Mar 31, 2021 | 61,000.00 |
| Dec 31, 2020 | 594,000.00 |
| Dec 31, 2020 | 594,000.00 |
| Sep 30, 2020 | 284,000.00 |
| Sep 30, 2020 | 284,000.00 |
| Jun 30, 2020 | -93,000.00 |
| Jun 30, 2020 | -93,000.00 |
| Mar 31, 2020 | -99,000.00 |
| Mar 31, 2020 | -99,000.00 |
| Dec 31, 2019 | -273,000.00 |
| Dec 31, 2019 | -273,000.00 |
| Sep 30, 2019 | 288,000.00 |
| Sep 30, 2019 | 288,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Mar 31, 2019 | -32,000.00 |
| Mar 31, 2019 | -32,000.00 |
| Dec 31, 2018 | -372,000.00 |
| Dec 31, 2018 | -372,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Jun 30, 2018 | 231,000.00 |
| Jun 30, 2018 | 231,000.00 |
| Mar 31, 2018 | -518,000.00 |
| Mar 31, 2018 | -518,000.00 |
| Dec 31, 2017 | 564,000.00 |
| Dec 31, 2017 | 564,000.00 |
| Sep 30, 2017 | 52,000.00 |
| Sep 30, 2017 | 52,000.00 |
| Jun 30, 2017 | -1.11 Mn |
| Jun 30, 2017 | -1.11 Mn |
| Mar 31, 2017 | 527,000.00 |
| Mar 31, 2017 | 527,000.00 |
| Dec 31, 2016 | -341,000.00 |
| Dec 31, 2016 | -341,000.00 |
| Sep 30, 2016 | 16,000.00 |
| Sep 30, 2016 | 16,000.00 |
| Jun 30, 2016 | 407,000.00 |
| Jun 30, 2016 | 407,000.00 |
| Mar 31, 2016 | -32,000.00 |
| Mar 31, 2016 | -32,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Sep 30, 2015 | 356,000.00 |
| Sep 30, 2015 | 356,000.00 |
| Jun 30, 2015 | -84,000.00 |
| Jun 30, 2015 | -84,000.00 |
| Mar 31, 2015 | -43,000.00 |
| Mar 31, 2015 | -43,000.00 |
| Dec 31, 2014 | -110,000.00 |
| Dec 31, 2014 | -110,000.00 |
| Sep 30, 2014 | 74,000.00 |
| Sep 30, 2014 | 74,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Mar 31, 2014 | -117,000.00 |
| Mar 31, 2014 | -117,000.00 |
| Dec 31, 2013 | 258,000.00 |
| Dec 31, 2013 | 258,000.00 |
| Sep 30, 2013 | 27,000.00 |
| Sep 30, 2013 | 27,000.00 |
| Jun 30, 2013 | -17,000.00 |
| Jun 30, 2013 | -17,000.00 |
| Mar 31, 2013 | 88,000.00 |
| Mar 31, 2013 | 88,000.00 |
| Dec 31, 2012 | 81,000.00 |
| Dec 31, 2012 | 81,000.00 |
| Sep 30, 2012 | -61,000.00 |
| Sep 30, 2012 | -61,000.00 |
| Jun 30, 2012 | -97,000.00 |
| Jun 30, 2012 | -97,000.00 |
| Mar 31, 2012 | -160,000.00 |
| Mar 31, 2012 | -160,000.00 |
| Dec 31, 2011 | 164,000.00 |
| Dec 31, 2011 | 164,000.00 |
| Sep 30, 2011 | -59,000.00 |
| Sep 30, 2011 | -59,000.00 |
| Jun 30, 2011 | -202,000.00 |
| Jun 30, 2011 | -202,000.00 |
| Mar 31, 2011 | -123,000.00 |
| Mar 31, 2011 | -123,000.00 |
| Dec 31, 2010 | 290,000.00 |
| Dec 31, 2010 | 290,000.00 |
| Sep 30, 2010 | -85,000.00 |
| Sep 30, 2010 | -85,000.00 |